Saturday, May 25, 2013 6:06pm EDT
AGN - Allergan Inc - Insider Transactions
SEC Form 4 |
Date |
Sym |
Company |
Insider |
Title |
Shares |
Transaction |
Value |
|---|---|---|---|---|---|---|---|---|
May 15 2013 | AGN | Allergan Inc | Jones Trevor M | Director | 1,000 | Option exercise at $36.49 | $36,490 | |
May 15 2013 | AGN | Allergan Inc | Jones Trevor M | Director | 2,000 | Sale at $103.40 | $206,800 | |
MMay 8 2013 | AGN | Allergan Inc | Edwards Jeffrey L | EVP, Fin, Bus. Dev., CFO | 84,000 | Option exercise at $57.81 | $4,856,400 | |
MMay 8 2013 | AGN | Allergan Inc | Edwards Jeffrey L | EVP, Fin, Bus. Dev., CFO | 84,000 | Sale at $103.49 | $8,693,509 | |
Apr 30 2013 | AGN | Allergan Inc | McDonnell Peter J | Director | 3,102 | Grant at $0.00 | $0 | |
Apr 30 2013 | AGN | Allergan Inc | Ray Russell T | Director | 3,102 | Grant at $0.00 | $0 | |
Apr 30 2013 | AGN | Allergan Inc | Lavigne Louis J Jr | Director | 3,102 | Grant at $0.00 | $0 | |
Apr 30 2013 | AGN | Allergan Inc | Gallagher Michael R | Director | 1,551 | Grant at $0.00 | $0 | |
Apr 30 2013 | AGN | Allergan Inc | Jones Trevor M | Director | 289 | Option payment at $113.55 | $32,816 | |
Apr 30 2013 | AGN | Allergan Inc | Jones Trevor M | Director | 3,102 | Grant at $0.00 | $0 | |
Apr 30 2013 | AGN | Allergan Inc | Dunsire Deborah | Director | 1,551 | Grant at $0.00 | $0 | |
Apr 30 2013 | AGN | Allergan Inc | Proctor Timothy D | Director | 3,102 | Grant at $0.00 | $0 | |
Apr 29 2013 | AGN | Allergan Inc | Ryan Stephen J | Director | 4,282 | Option exercise at $0.00 | $0 | |
May 1 2013 | AGN | Allergan Inc | Boyer Herbert W Ph D | Director | 18,225 | Option exercise at $0.00 | $0 | |
Apr 15 2013 | AGN | Allergan Inc | Jones Trevor M | Director | 1,000 | Option exercise at $60.60 | $60,600 | |
Apr 15 2013 | AGN | Allergan Inc | Jones Trevor M | Director | 2,000 | Sale at $115.74 | $231,480 | |
Apr 11 2013 | AGN | Allergan Inc | Whitcup Scott M | EVP, R, D, CSO | 12,005 | Option exercise at $36.15 | $433,981 | |
Apr 11 2013 | AGN | Allergan Inc | Whitcup Scott M | EVP, R, D, CSO | 12,005 | Sale at $115.00 | $1,380,575 | |
Apr 3 2013 | AGN | Allergan Inc | Whitcup Scott M | EVP, R, D, CSO | 13,195 | Option exercise at $36.15 | $476,999 | |
Apr 3 2013 | AGN | Allergan Inc | Whitcup Scott M | EVP, R, D, CSO | 13,195 | Sale at $115.00 | $1,517,425 | |
Apr 1 2013 | AGN | Allergan Inc | Whitcup Scott M | EVP, R, D, CSO | 8,000 | Option exercise at $41.24 | $329,920 | |
Apr 1 2013 | AGN | Allergan Inc | Whitcup Scott M | EVP, R, D, CSO | 8,000 | Sale at $111.70 | $893,622 | |
Mar 26 2013 | AGN | Allergan Inc | Whitcup Scott M | EVP, R, D, CSO | 11,484 | Option exercise at $36.15 | $415,147 | |
Mar 26 2013 | AGN | Allergan Inc | Whitcup Scott M | EVP, R, D, CSO | 11,484 | Sale at $112.00 | $1,286,208 | |
MMar 21 2013 | AGN | Allergan Inc | Whitcup Scott M | EVP, R, D, CSO | 6,116 | Option exercise at $36.15 | $221,093 | |
MMar 21 2013 | AGN | Allergan Inc | Whitcup Scott M | EVP, R, D, CSO | 6,116 | Sale at $112.00 | $684,992 | |
Mar 15 2013 | AGN | Allergan Inc | Jones Trevor M | Director | 1,000 | Option exercise at $60.60 | $60,600 | |
Mar 15 2013 | AGN | Allergan Inc | Jones Trevor M | Director | 2,000 | Sale at $108.68 | $217,360 | |
Mar 6 2013 | AGN | Allergan Inc | Ryan Stephen J | Director | 300 | Gift at $0.00 | $0 | |
Mar 5 2013 | AGN | Allergan Inc | Ryan Stephen J | Director | 5,700 | Option exercise at $60.60 | $345,420 | |
Mar 5 2013 | AGN | Allergan Inc | Ryan Stephen J | Director | 5,700 | Sale at $110.00 | $627,000 | |
MFeb 28 2013 | AGN | Allergan Inc | Gangolli Julian S | CVP, Pres, North America | 8,602 | Gift at $0.00 | $0 | |
Feb 20 2013 | AGN | Allergan Inc | Endicott David J. | CVP, President, AGN Med | 2,794 | Option payment at $108.08 | $301,976 | |
Feb 20 2013 | AGN | Allergan Inc | Gangolli Julian S | CVP, Pres, North America | 2,699 | Option payment at $108.08 | $291,708 | |
Feb 20 2013 | AGN | Allergan Inc | Barlow James F | SR. VP, Corp. Controller (PAO) | 1,278 | Option payment at $108.08 | $138,126 | |
Feb 20 2013 | AGN | Allergan Inc | Whitcup Scott M | EVP, R, D, CSO | 5,218 | Option payment at $108.08 | $563,961 | |
Feb 15 2013 | AGN | Allergan Inc | Edwards Jeffrey L | EVP, Fin, Bus. Dev., CFO | 201 | Option payment at $108.02 | $21,712 | |
Feb 15 2013 | AGN | Allergan Inc | Endicott David J. | CVP, President, AGN Med | 225 | Option payment at $108.02 | $24,305 | |
Feb 15 2013 | AGN | Allergan Inc | Whitcup Scott M | EVP, R, D, CSO | 434 | Option payment at $108.02 | $46,881 | |
Feb 15 2013 | AGN | Allergan Inc | Ingram Douglas S | EVP, President, EAME | 357 | Option payment at $108.02 | $38,563 | |
Feb 15 2013 | AGN | Allergan Inc | Jones Trevor M | Director | 1,000 | Option exercise at $60.60 | $60,600 | |
Feb 15 2013 | AGN | Allergan Inc | Jones Trevor M | Director | 2,000 | Sale at $107.82 | $215,640 | |
MNov 29 2012 | AGN | Allergan Inc | Endicott David J. | CVP, President, AGN Med | 1,940 | Option exercise at $64.47 | $125,072 | |
MNov 29 2012 | AGN | Allergan Inc | Endicott David J. | CVP, President, AGN Med | 1,940 | Sale at $92.33 | $179,115 | |
Jan 15 2013 | AGN | Allergan Inc | Jones Trevor M | Director | 1,000 | Option exercise at $60.60 | $60,600 | |
Jan 15 2013 | AGN | Allergan Inc | Jones Trevor M | Director | 2,000 | Sale at $103.30 | $206,600 | |
Jan 15 2013 | AGN | Allergan Inc | Ryan Stephen J | Director | 5,700 | Option exercise at $60.60 | $345,420 | |
Jan 15 2013 | AGN | Allergan Inc | Ryan Stephen J | Director | 5,700 | Sale at $103.30 | $588,810 | |
MJan 11 2013 | AGN | Allergan Inc | Gangolli Julian S | CVP, Pres, North America | 802 | Gift at $0.00 | $0 | |
Jan 4 2013 | AGN | Allergan Inc | Whitcup Scott M | EVP, R, D, CSO | 24,000 | Option exercise at $41.24 | $989,760 | |
Jan 4 2013 | AGN | Allergan Inc | Whitcup Scott M | EVP, R, D, CSO | 24,000 | Sale at $96.80 | $2,323,200 | |
MDec 31 2012 | AGN | Allergan Inc | Gangolli Julian S | CVP, Pres, North America | 353 | Option payment at $91.73 | $32,381 | |
Dec 13 2012 | AGN | Allergan Inc | Ryan Stephen J | Director | 594 | Gift at $0.00 | $0 | |
Dec 7 2012 | AGN | Allergan Inc | Whitcup Scott M | EVP, R, D, CSO | 6,800 | Option exercise at $30.12 | $204,850 | |
Dec 7 2012 | AGN | Allergan Inc | Whitcup Scott M | EVP, R, D, CSO | 6,800 | Sale at $91.23 | $620,391 | |
Nov 29 2012 | AGN | Allergan Inc | Endicott David J. | CVP, President, AGN Med | 52,560 | Option exercise at $64.47 | $3,388,543 | |
Nov 29 2012 | AGN | Allergan Inc | Endicott David J. | CVP, President, AGN Med | 52,560 | Sale at $92.43 | $4,857,974 | |
MNov 27 2012 | AGN | Allergan Inc | Gangolli Julian S | CVP, Pres, North America | 90,000 | Option exercise at $52.42 | $4,717,800 | |
MNov 27 2012 | AGN | Allergan Inc | Gangolli Julian S | CVP, Pres, North America | 90,000 | Sale at $91.89 | $8,269,941 | |
MNov 19 2012 | AGN | Allergan Inc | Gallagher Michael R | Director | 104,100 | Gift at $0.00 | $0 | |
MNov 26 2012 | AGN | Allergan Inc | Gallagher Michael R | Director | 50,500 | Sale at $91.78 | $4,634,722 | |
MNov 27 2012 | AGN | Allergan Inc | Gallagher Michael R | Director | 30,400 | Option exercise at $46.36 | $1,409,234 | |
Nov 26 2012 | AGN | Allergan Inc | Jones Trevor M | Director | 1,000 | Option exercise at $60.60 | $60,600 | |
Nov 26 2012 | AGN | Allergan Inc | Jones Trevor M | Director | 2,500 | Sale at $91.30 | $228,250 | |
MNov 21 2012 | AGN | Allergan Inc | Ray Russell T | Director | 33,000 | Sale at $91.05 | $3,004,565 | |
MNov 21 2012 | AGN | Allergan Inc | Ray Russell T | Director | 15,000 | Option exercise at $39.74 | $596,125 | |
Nov 20 2012 | AGN | Allergan Inc | Edwards Jeffrey L | EVP, Fin, Bus. Dev., CFO | 60,000 | Option exercise at $55.98 | $3,358,500 | |
Nov 20 2012 | AGN | Allergan Inc | Edwards Jeffrey L | EVP, Fin, Bus. Dev., CFO | 59,000 | Sale at $90.95 | $5,366,121 | |
Nov 20 2012 | AGN | Allergan Inc | Diradoorian Raymond H | EVPGlobal Technical Operations | 25,000 | Option exercise at $55.98 | $1,399,375 | |
Nov 20 2012 | AGN | Allergan Inc | Diradoorian Raymond H | EVPGlobal Technical Operations | 25,000 | Sale at $91.02 | $2,275,585 | |
Nov 21 2012 | AGN | Allergan Inc | Hudson Dawn E | Director | 5,000 | Sale at $91.00 | $455,000 | |
Oct 26 2012 | AGN | Allergan Inc | Jones Trevor M | Director | 1,000 | Option exercise at $60.60 | $60,600 | |
Oct 26 2012 | AGN | Allergan Inc | Jones Trevor M | Director | 2,500 | Sale at $91.30 | $228,250 | |
Oct 17 2012 | AGN | Allergan Inc | Whitcup Scott M | EVP, R, D, CSO | 5,000 | Option exercise at $30.12 | $150,625 | |
Oct 17 2012 | AGN | Allergan Inc | Whitcup Scott M | EVP, R, D, CSO | 5,000 | Sale at $94.70 | $473,500 | |
MSep 21 2012 | AGN | Allergan Inc | Pyott David E I | Chairman, President, CEO | 38,946 | Gift at $0.00 | $0 | |
MOct 4 2012 | AGN | Allergan Inc | Pyott David E I | Chairman, President, CEO | 616,300 | Sale at $93.73 | $57,764,068 | |
MOct 4 2012 | AGN | Allergan Inc | Pyott David E I | Chairman, President, CEO | 619,000 | Option exercise at $39.10 | $24,204,875 | |
Oct 1 2012 | AGN | Allergan Inc | Whitcup Scott M | EVP, R, D, CSO | 6,000 | Option exercise at $30.12 | $180,750 | |
Oct 1 2012 | AGN | Allergan Inc | Whitcup Scott M | EVP, R, D, CSO | 6,000 | Sale at $92.70 | $556,200 | |
MSep 26 2012 | AGN | Allergan Inc | Jones Trevor M | Director | 2,500 | Sale at $91.92 | $229,800 | |
Sep 26 2012 | AGN | Allergan Inc | Jones Trevor M | Director | 1,000 | Option exercise at $60.60 | $60,600 | |
Sep 12 2012 | AGN | Allergan Inc | Jones Trevor M | Director | 1,000 | Option exercise at $60.60 | $60,600 | |
Sep 12 2012 | AGN | Allergan Inc | Jones Trevor M | Director | 1,000 | Sale at $90.00 | $90,000 | |
Aug 30 2012 | AGN | Allergan Inc | Ingram Douglas S | EVP, President, EAME | 100,000 | Option exercise at $36.15 | $3,615,000 | |
Aug 30 2012 | AGN | Allergan Inc | Ingram Douglas S | EVP, President, EAME | 100,000 | Sale at $85.78 | $8,578,230 | |
MMar 9 2012 | AGN | Allergan Inc | Lavigne Louis J Jr | Director | 50,400 | Gift at $0.00 | $0 | |
Aug 29 2012 | AGN | Allergan Inc | Lavigne Louis J Jr | Director | 15,000 | Sale at $85.04 | $1,275,600 | |
Aug 27 2012 | AGN | Allergan Inc | Jones Trevor M | Director | 1,500 | Sale at $85.43 | $128,145 | |
MAug 24 2012 | AGN | Allergan Inc | Ryan Stephen J | Director | 86,414 | Gift at $0.00 | $0 | |
MAug 3 2012 | AGN | Allergan Inc | Ryan Stephen J | Director | 46,800 | Option exercise at $47.28 | $2,212,732 | |
MAug 3 2012 | AGN | Allergan Inc | Ryan Stephen J | Director | 46,800 | Sale at $85.76 | $4,013,473 | |
Aug 1 2012 | AGN | Allergan Inc | Jones Trevor M | Director | 1,000 | Option exercise at $60.60 | $60,600 | |
Aug 1 2012 | AGN | Allergan Inc | Jones Trevor M | Director | 1,000 | Sale at $90.00 | $90,000 | |
MJul 27 2012 | AGN | Allergan Inc | Diradoorian Raymond H | EVPGlobal Technical Operations | 295 | Option payment at $86.25 | $25,444 | |
Jul 26 2012 | AGN | Allergan Inc | Jones Trevor M | Director | 1,500 | Sale at $84.70 | $127,050 | |
MJun 26 2012 | AGN | Allergan Inc | Jones Trevor M | Director | 2,500 | Sale at $90.02 | $225,060 | |
Jun 26 2012 | AGN | Allergan Inc | Jones Trevor M | Director | 1,000 | Option exercise at $60.60 | $60,600 | |
May 30 2012 | AGN | Allergan Inc | Whitcup Scott M | EVP, R, D, CSO | 1,500 | Option exercise at $30.12 | $45,188 | |
May 30 2012 | AGN | Allergan Inc | Whitcup Scott M | EVP, R, D, CSO | 1,500 | Sale at $90.71 | $136,062 |
D Derivative transaction exists
M Multiple transactions summarized; earliest reported transaction date and average weighted transaction price
Yahoo Finance